BFM
NYMX

Boothbay Fund Management’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Boothbay Fund Management’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,265
Closed -$57K – 2290
2021
Q2 		$57K Buy
+36,265
New +$67.2K ﹤0.01% 1763

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.7B AUM 31.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Boothbay Fund Management's NYMX Position: Q3 2021 in Review

Boothbay Fund Management sold out of Nymox Pharmaceutical Corp (NYMX) in Q3 2021, closing a stake of 36,265 shares — an estimated $57K sold.

Boothbay Fund Management first reported a position in NYMX in Q2 2021 and held it in 1 quarter. The position peaked at $57K in Q2 2021. 38 funds tracked by Wall St. Rank hold NYMX as of Q3 2021.

  • Boothbay Fund Management reported no remaining Nymox Pharmaceutical Corp position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 36,265 Nymox Pharmaceutical Corp shares in Q3 2021, an estimated $57K.
  • Boothbay Fund Management first reported a position in Nymox Pharmaceutical Corp in Q2 2021 and held it in 1 quarter.
  • Boothbay Fund Management's Nymox Pharmaceutical Corp position peaked at $57K in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.